CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 1,088 enrolled
Drug / intervention
Chlorhexidine-impregnated foam dressingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00548132
NCT00548132Phase 4Completed
CompareCT.gov

Reducing Catheter-Related Bloodstream Infections in the ICU With a Chlorhexidine-Impregnated Sponge (BIOPATCH)

Washington University School of Medicine·interventional·Posted Oct 23, 2007·Updated Sep 12, 2013

In Brief

A Phase 4 clinical trial evaluating Chlorhexidine-impregnated foam dressing for Catheter-related Bloodstream Infection. Completed, enrolled 1,088 participants across 1 site.

Detailed Summary

We proposed to perform a prospective randomized controlled trial to study the effect of the use of a commercially-available chlorhexidine-impregnated sponge (Biopatch) as part of central venous catheter care on catheter-related bloodstream infections among patients in two Barnes-Jewish Hospital ICUs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCatheter-related Bloodstream Infection
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 23, 2007
Enrollment StartFeb 1, 2006
Primary CompletionFeb 1, 2008
Study CompletionMay 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 18.7 years ago

Interventions

Chlorhexidine-impregnated foam dressingdevice

Patients in the treatment arm will have the Biopatch incorporated into their catheter care protocol. ICU nurses were instructed on the proper use of this novel dressing/sponge. Catheter dressing changes will only be done every 7 days unless there is visible blood, soiling underneath the dressing, or if the dressing comes off.